A Phase 1/1b Open-Label Dose Escalation and Expansion Study of Bcl-2 inhibitor BGB-11417 in Patients with Mature B-Cell Malignancies

Project: Research

Project Details

StatusActive
Effective start/end date25/02/20 → 24/02/25
View all
View less

Keywords

  • clinical trial
  • phase 1 study
  • treatment efficacy
  • lymphoma
  • leukemia